|
1
|
Callender T, Woodward M, Roth G, Farzadfar
F, Lemarie JC, Gicquel S, Atherton J, Rahimzadeh S, Ghaziani M,
Shaikh M, et al: Heart failure care in low- and middle-income
countries: A systematic review and meta-analysis. PLoS Med.
11:e10016992014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ibáñez B, Heusch G, Ovize M and Van de
Werf F: Evolving therapies for myocardial ischemia/reperfusion
injury. J Am Coll Cardiol. 65:1454–1471. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eapen ZJ, Tang WH, Felker GM, Hernandez
AF, Mahaffey KW, Lincoff AM and Roe MT: Defining heart failure end
points in ST-segment elevation myocardial infarction trials:
Integrating past experiences to chart a path forward. Circ
Cardiovasc Qual Outcomes. 5:594–600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reeve JL, Duffy AM, O'Brien T and Samali
A: Don't lose heart - therapeutic value of apoptosis prevention in
the treatment of cardiovascular disease. J Cell Mol Med. 9:609–622.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Piper HM, García-Dorado D and Ovize M: A
fresh look at reperfusion injury. Cardiovasc Res. 38:291–300. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cannon RO III: Mechanisms, management and
future directions for reperfusion injury after acute myocardial
infarction. Nat Clin Pract Cardiovasc Med. 2:88–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reimer KA, Jennings RB and Tatum AH:
Pathobiology of acute myocardial ischemia: Metabolic, functional
and ultrastructural studies. Am J Cardiol. 52:72A–81A. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ladilov YV, Siegmund B and Piper HM:
Protection of reoxygenated cardiomyocytes against hypercontracture
by inhibition of Na+/H+ exchange. Am J
Physiol. 268:H1531–H1539. 1995.PubMed/NCBI
|
|
10
|
Inserte J, Hernando V and Garcia-Dorado D:
Contribution of calpains to myocardial ischaemia/reperfusion
injury. Cardiovasc Res. 96:23–31. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruiz-Meana M, García-Dorado D, González
MA, Barrabés JA and Soler-Soler J: Effect of osmotic stress on
sarcolemmal integrity of isolated cardiomyocytes following
transient metabolic inhibition. Cardiovasc Res. 30:64–69. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Barrabés JA, Garcia-Dorado D, Ruiz-Meana
M, Piper HM, Solares J, González MA, Oliveras J, Herrejón MP and
Soler J Soler: Myocardial segment shrinkage during coronary
reperfusion in situ. Relation to hypercontracture and myocardial
necrosis. Pflugers Arch. 431:519–526. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Halestrap AP, Clarke SJ and Javadov SA:
Mitochondrial permeability transition pore opening during
myocardial reperfusion - a target for cardioprotection. Cardiovasc
Res. 61:372–385. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ruiz-Meana M, Inserte J, Fernandez-Sanz C,
Hernando V, Miro-Casas E, Barba I and Garcia-Dorado D: The role of
mitochondrial permeability transition in reperfusion-induced
cardiomyocyte death depends on the duration of ischemia. Basic Res
Cardiol. 106:1259–1268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Buja LM: Myocardial ischemia and
reperfusion injury. Cardiovasc Pathol. 14:170–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Heusch G: Cardioprotection: Chances and
challenges of its translation to the clinic. Lancet. 381:166–175.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao ZQ, Corvera JS, Halkos ME, Kerendi F,
Wang NP, Guyton RA and Vinten-Johansen J: Inhibition of myocardial
injury by ischemic postconditioning during reperfusion: Comparison
with ischemic preconditioning. Am J Physiol Heart Circ Physiol.
285:H579–H588. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rodríguez-Sinovas A, Cabestrero A, del
Blanco García B, Inserte J, García A and García-Dorado D:
Intracoronary acid infusion as an alternative to ischemic
postconditioning in pigs. Basic Res Cardiol. 104:761–771. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Inserte J, Ruiz-Meana M, Rodríguez-Sinovas
A, Barba I and Garcia-Dorado D: Contribution of delayed
intracellular pH recovery to ischemic postconditioning protection.
Antioxid Redox Signal. 14:923–939. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Inserte J, Barba I, Poncelas-Nozal M,
Hernando V, Agulló L, Ruiz-Meana M and Garcia-Dorado D: cGMP/PKG
pathway mediates myocardial postconditioning protection in rat
hearts by delaying normalization of intracellular acidosis during
reperfusion. J Mol Cell Cardiol. 50:903–909. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hausenloy DJ and Yellon DM: Remote
ischaemic preconditioning: Underlying mechanisms and clinical
application. Cardiovasc Res. 79:377–386. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thielmann M, Wendt D, Tsagakis K, Price V,
Dohle DS, Pasa S and Kottenberg E: Remote ischemic preconditioning:
The surgeon's perspective. J Cardiovasc Med (Hagerstown).
14:187–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gritsopoulos G, Iliodromitis EK, Zoga A,
Farmakis D, Demerouti E, Papalois A, Paraskevaidis IA and
Kremastinos DT: Remote postconditioning is more potent than classic
postconditioning in reducing the infarct size in anesthetized
rabbits. Cardiovasc Drugs Ther. 23:193–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hausenloy DJ, Iliodromitis EK, Andreadou
I, Papalois A, Gritsopoulos G, Anastasiou-Nana M, Kremastinos DT
and Yellon DM: Investigating the signal transduction pathways
underlying remote ischemic conditioning in the porcine heart.
Cardiovasc Drugs Ther. 26:87–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tissier R, Chenoune M, Ghaleh B, Cohen MV,
Downey JM and Berdeaux A: The small chill: Mild hypothermia for
cardioprotection? Cardiovasc Res. 88:406–414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hale SL and Kloner RA: Mild hypothermia as
a cardioprotective approach for acute myocardial infarction:
Laboratory to clinical application. J Cardiovasc Pharmacol Ther.
16:131–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Götberg M, Olivecrona GK, Koul S, Carlsson
M, Engblom H, Ugander M, van der Pals J, Algotsson L, Arheden H and
Erlinge D: A pilot study of rapid cooling by cold saline and
endovascular cooling before reperfusion in patients with
ST-elevation myocardial infarction. Circ Cardiovasc Interv.
3:400–407. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rupprecht HJ, vom Dahl J, Terres W,
Seyfarth KM, Richardt G, Schultheibeta HP, Buerke M, Sheehan FH and
Drexler H: Cardioprotective effects of the Na(+)/H(+) exchange
inhibitor cariporide in patients with acute anterior myocardial
infarction undergoing direct PTCA. Circulation. 101:2902–2908.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamada K, Matsui K, Satoh K, Kitano M,
Yamamoto S and Ohashi N: Reduction of myocardial infarct size by
SM-20550, a novel Na(+)/H(+) exchange inhibitor, in rabbits. Eur J
Pharmacol. 404:201–212. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karmazyn M: NHE-1: Still a viable
therapeutic target. J Mol Cell Cardiol. 61:77–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang XM, Philipp S, Downey JM and Cohen
MV: Atrial natriuretic peptide administered just prior to
reperfusion limits infarction in rabbit hearts. Basic Res Cardiol.
101:311–318. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Das A, Durrant D, Salloum FN, Xi L and
Kukreja RC: PDE5 inhibitors as therapeutics for heart disease,
diabetes and cancer. Pharmacol Ther. 147:12–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Padilla F, Garcia-Dorado D, Agulló L,
Barrabés JA, Inserte J, Escalona N, Meyer M, Mirabet M, Pina P and
Soler-Soler J: Intravenous administration of the natriuretic
peptide urodilatin at low doses during coronary reperfusion limits
infarct size in anesthetized pigs. Cardiovasc Res. 51:592–600.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao F, Gao E, Yue TL, Ohlstein EH, Lopez
BL, Christopher TA and Ma XL: Nitric oxide mediates the
antiapoptotic effect of insulin in myocardial ischemia-reperfusion:
The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase
phosphorylation. Circulation. 105:1497–1502. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suranadi IW, Demaison L, Chaté V, Peltier
S, Richardson M and Leverve X: An increase in the redox state
during reperfusion contributes to the cardioprotective effect of
GIK solution. J Appl Physiol (1985). 113:775–784. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Selker HP, Beshansky JR, Sheehan PR,
Massaro JM, Griffith JL, D'Agostino RB, Ruthazer R, Atkins JM,
Sayah AJ, Levy MK, et al: Out-of-hospital administration of
intravenous glucose-insulin-potassium in patients with suspected
acute coronary syndromes: The IMMEDIATE randomized controlled
trial. JAMA. 307:1925–1933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS,
Drucker DJ and Husain M: Cardioprotective and vasodilatory actions
of glucagon-like peptide 1 receptor are mediated through both
glucagon-like peptide 1 receptor-dependent and -independent
pathways. Circulation. 117:2340–2350. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Timmers L, Henriques JP, de Kleijn DP,
Devries JH, Kemperman H, Steendijk P, Verlaan CW, Kerver M, Piek
JJ, Doevendans PA, et al: Exenatide reduces infarct size and
improves cardiac function in a porcine model of ischemia and
reperfusion injury. J Am Coll Cardiol. 53:501–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lønborg J, Vejlstrup N, Kelbæk H, Bøtker
HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K,
Clemmensen P, et al: Exenatide reduces reperfusion injury in
patients with ST-segment elevation myocardial infarction. Eur Heart
J. 33:1491–1499. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mahaffey KW, Puma JA, Barbagelata NA,
DiCarli MF, Leesar MA, Browne KF, Eisenberg PR, Bolli R, Casas AC,
Molina-Viamonte V, et al: Adenosine as an adjunct to thrombolytic
therapy for acute myocardial infarction: results of a multicenter,
randomized, placebo-controlled trial: the Acute Myocardial
Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol.
34:1711–1720. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ross AM, Gibbons RJ, Stone GW, Kloner RA
and Alexander RW: AMISTAD-II Investigators: A randomized,
double-blinded, placebo-controlled multicenter trial of adenosine
as an adjunct to reperfusion in the treatment of acute myocardial
infarction (AMISTAD-II). J Am Coll Cardiol. 45:1775–1780. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Garcia-Dorado D, García-del-Blanco B,
Otaegui I, Rodríguez-Palomares J, Pineda V, Gimeno F, Ruiz-Salmerón
R, Elizaga J, Evangelista A, Fernandez-Avilés F, et al:
Intracoronary injection of adenosine before reperfusion in patients
with ST-segment elevation myocardial infarction: A randomized
controlled clinical trial. Int J Cardiol. 177:935–941. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Piot C, Croisille P, Staat P, Thibault H,
Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant
D, et al: Effect of cyclosporine on reperfusion injury in acute
myocardial infarction. N Engl J Med. 359:473–481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ghaffari S, Kazemi B, Toluey M and
Sepehrvand N: The effect of prethrombolytic cyclosporine-A
injection on clinical outcome of acute anterior ST-elevation
myocardial infarction. Cardiovasc Ther. 31:e34–e39. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hausenloy DJ and Yellon DM: Targeting
myocardial reperfusion injury - the search continues. N Engl J Med.
373:1073–1075. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ibanez B, Cimmino G, Prat-González S,
Vilahur G, Hutter R, García MJ, Fuster V, Sanz J, Badimon L and
Badimon JJ: The cardioprotection granted by metoprolol is
restricted to its administration prior to coronary reperfusion. Int
J Cardiol. 147:428–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
García-Prieto J, García-Ruiz JM, Sanz-Rosa
D, Pun A, García-Alvarez A, Davidson SM, Fernández-Friera L,
Nuno-Ayala M, Fernández-Jiménez R, Bernal JA, et al: β3 adrenergic
receptor selective stimulation during ischemia/reperfusion improves
cardiac function in translational models through inhibition of mPTP
opening in cardiomyocytes. Basic Res Cardiol. 109:4222014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ibanez B, Macaya C, Sánchez-Brunete V,
Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A,
García-Ruiz JM, García-Álvarez A, Iñiguez A, et al: Effect of early
metoprolol on infarct size in ST-segment-elevation myocardial
infarction patients undergoing primary percutaneous coronary
intervention: The Effect of Metoprolol in Cardioprotection During
an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation.
128:1495–1503. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sorrentino SA, Doerries C, Manes C, Speer
T, Dessy C, Lobysheva I, Mohmand W, Akbar R, Bahlmann F, Besler C,
et al: Nebivolol exerts beneficial effects on endothelial function,
early endothelial progenitor cells, myocardial neovascularization,
and left ventricular dysfunction early after myocardial infarction
beyond conventional β1-blockade. J Am Coll Cardiol. 57:601–611.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rakowski T, Zalewski J, Legutko J, Bartus
S, Rzeszutko L, Dziewierz A, Sorysz D, Bryniarski L, Zmudka K,
Kaluza GL, et al: Early abciximab administration before primary
percutaneous coronary intervention improves infarct-related artery
patency and left ventricular function in high-risk patients with
anterior wall myocardial infarction: A randomized study. Am Heart
J. 153:360–365. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Thiele H, Schindler K, Friedenberger J,
Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S,
Kivelitz D, et al: Intracoronary compared with intravenous bolus
abciximab application in patients with ST-elevation myocardial
infarction undergoing primary percutaneous coronary intervention:
The randomized Leipzig immediate percutaneous coronary intervention
abciximab IV versus IC in ST-elevation myocardial infarction trial.
Circulation. 118:49–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang XM, Liu Y, Cui L, Yang X, Liu Y,
Tandon N, Kambayashi J, Downey JM and Cohen MV: Platelet P2Y(1)(2)
blockers confer direct postconditioning-like protection in
reperfused rabbit hearts. J Cardiovasc Pharmacol Ther. 18:251–262.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bajaj RR, Mohammad A, Hong T, Irfan A,
Sharieff W, Bagnall A, Christie JA, Kutryk MJ, Chisholm RJ and
Cheema AN: Comparison of abciximab and eptifibatide on angiographic
and clinical outcomes in rescue percutaneous coronary intervention
for failed fibrinolytic therapy. J Invasive Cardiol. 22:347–352.
2010.PubMed/NCBI
|
|
54
|
No authors listed, . ISIS-4: a randomised
factorial trial assessing early oral captopril, oral mononitrate,
and intravenous magnesium sulphate in 58,050 patients with
suspected acute myocardial infarction. ISIS-4 (Fourth International
Study of Infarct Survival) Collaborative Group. Lancet.
345:669–685. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ambrosio G, Del Pinto M, Tritto I, Agnelli
G, Bentivoglio M, Zuchi C, Anderson FA, Gore JM, López-Sendón J,
Wyman A, et al: GRACE Investigators: Chronic nitrate therapy is
associated with different presentation and evolution of acute
coronary syndromes: Insights from 52,693 patients in the Global
Registry of Acute Coronary Events. Eur Heart J. 31:430–438. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Leesar MA, Stoddard MF, Dawn B, Jasti VG,
Masden R and Bolli R: Delayed preconditioning-mimetic action of
nitroglycerin in patients undergoing coronary angioplasty.
Circulation. 103:2935–2941. 2001. View Article : Google Scholar : PubMed/NCBI
|
